Development of a Screening Assay to Measure the Loss of Antibacterial Activity in the Presence of Proteins: Its Use in Optimizing Compound Structure

Abstract

An assay quantifying the loss of antibacterial potency of compounds, originally identified via target-based screening, in the presence of increasing albumin concentration was developed and used as a technique to measure potential association of com-pounds with proteins unrelated to their molecular target. Minimum inhibitory concentrations (MICs) of test compounds were measured against Staphylococcus aureus strain ATCC 6538 in the presence of 0-12 [.proportional]M bovine serum albumin (BSA). The linear regression coefficient r ² for the correlation between MIC and BSA concentration was ≥ 0.9 for 49 and > 0.5 for 62 out of a total of 69 compounds tested. The slope of these correlations varied widely from < 1 to 99, suggesting that the loss of potency due to a given concentration of BSA could vary from compound to compound due to wide variation in the apparent stoichiometry for protein-ligand association. Follow-up experiments using additional proteins and a fatty acid, oleic acid, showed that this compound:BSA association was not protein specific, but was likely driven by hydrophobicity. The method described in this report can be used to optimize compound design and minimize this undesirable effect. (Journal of Biomolecular Screening 2003:555-558)

References

1. McDevitt D, Payne DJ, Holmes DJ, Rosenberg M: Novel targets for the future development of antibacterial agents . J Appl Microbiol 2002;92(Suppl): 28S-34S .

2. Hilliard JJ, Goldschmidt RM, Licata L, et al: Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems . Antimicrob Agents Chemother 1999;43: 1693-1699 .

3. Grinius L, Stanton DT, Morris CM, et al: Profiling of drugs for membrane activity using liposomes as an in vitro model system . Drug Dev Ind Pharm 2002;28: 193-202 .

4. McGovern SL, Caselli E, Grigorieff N, et al: A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening . J Med Chem 2002;45: 1712-1722 .

5. Nerli B, Romanin D, Pico G: Structural specificity requirements in the binding of beta lactam antibiotics to human serum albumin . Chem Biol Interact 1997;104: 179-202 .

6. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed: Approved Standard M7-A4. Wayne (PA): NCCLS .

7. Craig WA, Ebert SC: Protein binding and its significance in antibacterial therapy . Infect Dis Clin North Am 1989;3: 407-414 .

8. Lu WP, Swoboda BEP, Kelly DP: Properties of the thiosulfate-oxidizing multi-enzyme system from Thiobacillus versutus . Biochim Biophys Acta 1985;828: 116-122 .